Evaluating Vascular Hyperpermeability-inducing Agents in the Skin with the Miles Assay
June 19th, 2018
16.6K views
Here, we present a protocol to measure the vascular leakage induced by intradermal administration of permeability promoting agents into the murine skin. This technique can be used to determine the ability of molecules to promote or inhibit vascular leakage or to study the molecular mechanisms that regulate vascular permeability.
Overview
This article presents a protocol for measuring vascular leakage in murine skin induced by permeability promoting agents. The technique aids in understanding the regulation of vascular permeability and the effects of various molecules.
Key Study Components
Area of Science
- Vascular biology
- Pharmacology
- Experimental medicine
Background
- Vascular permeability is crucial in various physiological and pathological processes.
- Understanding the mechanisms of vascular leakage can inform therapeutic strategies for diseases with edema.
- Common laboratory reagents are utilized in this procedure.
- Quick and simple execution makes it accessible for researchers.
Purpose of Study
- To measure the effects of permeability promoting agents on vascular leakage.
- To identify molecular targets for inhibiting vascular permeability.
- To explore signaling pathways involved in vascular regulation.
Methods Used
- Intradermal and intravenous injections of agents in mice.
- Use of Evans Blue Dye to quantify vascular leakage.
- Monitoring and recording injection sites and outcomes.
- Centrifugation and spectrophotometric analysis of samples.
Main Results
- VEGF significantly increases vascular leakage compared to vehicle control.
- Quantitative analysis shows a three-fold increase in leakage with VEGFA.
- Procedure can be completed in approximately two hours.
- Normalization of leakage data is essential for accurate results.
Conclusions
- This technique provides insights into vascular biology and permeability regulation.
- It can be combined with other methods to enhance research on vascular permeability.
- Future studies can leverage this protocol to test new therapeutic agents.
Frequently Asked Questions
What is the main goal of this protocol?
To measure vascular leakage in murine skin induced by permeability promoting agents.
How long does the procedure take?
The main segment of the procedure can be completed in about two hours.
What is the significance of using Evans Blue Dye?
Evans Blue Dye is used to quantify the extent of vascular leakage in the skin samples.
Why is it important to normalize leakage data?
Normalization accounts for nonspecific leakage and variations between individual mice.
Can this technique be used for drug testing?
Yes, it can be used to test the efficacy of drugs in inhibiting vascular permeability.
What are the implications of this research?
The findings can inform therapeutic strategies for diseases characterized by pathological edema.
Executive Industry Relevance
The Miles assay enables biopharma teams to quantify vascular hyperpermeability in vivo, supporting target validation for edema-related pathologies. By measuring dye leakage as a functional readout, the method provides mechanistic insight into permeability-regulating pathways. This accelerates de-risking of vascular targets and supports go/no-go decisions in preclinical programs focused on vascular stability.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Interrogates therapeutic hypotheses by identifying molecules that stimulate or inhibit vascular leakage in a disease-relevant system.
- Operational Value: Uses common laboratory reagents and standardized procedures to enable reproducible target engagement assessment.
- Predictive Value: Quantifies fold-change in leakage (e.g., three-fold increase with VEGFA) to support mechanistic de-risking and pathway clarification.
Screening & Assay Development
- Scientific Value: Prepares validated biological systems for downstream screening by establishing baseline vascular permeability responses.
- Operational Value: Enables assay standardization through normalization to vehicle control, reducing inter-animal variability.
- Scalability: Supports platform reuse across multiple agents and genetic models for comparative permeability profiling.
Translational & Preclinical Research
- Scientific Value: Maintains disease relevance by modeling vascular hyperpermeability in murine dermis, a key site of edema formation.
- Operational Value: Facilitates translational continuity from discovery through preclinical validation via quantitative leakage readouts.
- Risk Mitigation: Informs risk-adjusted advancement decisions by identifying agents capable of inducing or blocking hyperpermeability.
Pipeline & Workflow Integration
The assay fits within the discovery continuum from target identification to preclinical evaluation, providing functional vascular permeability data that informs lead optimization.
- Discovery Biology: Supports hypothesis testing of permeability-promoting or -inhibiting agents through direct measurement of dye extravasation.
- Screening: Delivers quantitative, reproducible outputs via spectrophotometric analysis of extracted Evans Blue dye, enabling compound comparison.
- Analytics: Generates normalized leakage metrics (e.g., fold-change over vehicle) that help teams compare conditions and assess target modulation.
- Translational Research: Connects to preclinical continuity by modeling a pathophysiological process relevant to edema-inducing diseases.
- Enterprise Reuse: Functions as a reusable capability across projects studying vascular regulators, reducing redundant model development.
Operational & Enterprise Impact
- Scientific Value: Provides predictive confidence in target validation by linking molecular agents to functional vascular outcomes.
- Operational Value: Ensures standardization and reproducibility through controlled injection protocols and data normalization.
- Strategic Value: Improves go/no-go decisions by reducing mechanistic ambiguity in vascular permeability pathways.
- Portfolio Impact: Enables risk-adjusted prioritization of vascular targets based on functional leakage data.
Implementation Considerations
- Requires expertise in murine handling, intravenous and intradermal injection techniques.
- Dependent on access to spectrophotometry, centrifuges, and sterile filtration equipment.
- Necessitates cross-team standardization of injection sites, timing, and dye extraction protocols.
- Adaptation considerations include genetic model variability and agent solubility in delivery vehicles.
- Practical limitations include technical difficulty of tail vein injection and dye extraction variability, as noted in source material.
Biopharma FAQs
Why does normalization of vascular leakage data matter for target validation?
Normalization accounts for nonspecific leakage and inter-animal variation, ensuring that observed changes are attributable to the test agent rather than baseline variability, which is critical for accurate target assessment in discovery programs.
How does independent variable isolation support mechanistic de-risking in vascular biology?
By intradermally injecting specific agents like VEGF or vehicle controls at defined doses and sites, the assay isolates the effect of the independent variable, enabling clear attribution of leakage changes to molecular mechanisms under study.
What quantitative dependent variable measurements enable lead identification in permeability assays?
Spectrophotometric measurement of extracted Evans Blue dye provides a quantitative readout of vascular leakage, allowing researchers to compare agent-induced effects (e.g., three-fold increase with VEGFA) and prioritize leads based on functional potency.
Why are replication requirements essential for cross-functional collaboration in vascular permeability studies?
Replicate injections at multiple sites and consistent timing across animals ensure data reliability, which is necessary for consistent interpretation between discovery, pharmacology, and preclinical teams evaluating vascular targets.
What statistical analysis capabilities are required before implementing the Miles assay in a discovery workflow?
The ability to calculate fold-change in optical density between agent and vehicle controls, perform group comparisons, and assess significance (e.g., via t-test or ANOVA) is required to derive meaningful conclusions from leakage data and support decision-making.
Chapters in this video
0:04
Title
1:01
Intravenous Injection of Evans Blue Dye
2:48
Stimulation of Vascular Hyperpermeability
4:27
Quantification of the Accumulated Evans Blue within the Dermis
6:22
Results: Use of the Miles Assay to Detect Vascular Leakage Triggered by Intradermal Injection of VEGF into C57/BI6 Mice
7:39
Conclusion
